The company expects to launch more than 20 pivotal late-stage trials this year.

Is Pfizer stock a buy at under 9x earnings? Yes. It is.

Overview: Pfizer stock is trading near $25.86 with moderate upside potential based on the forecast range of up to ...

In the last six months Pfizer’s stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and J&J (NYSE: JNJ) primarily due to ...

Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read ...

SHANGHAI, CHINA - 2025/11/08: The Pfizer logo is presented at the 8th China International Import Expo. (Photo by Sheldon Cooper/SOPA Images/LightRocket via Getty Images) Pfizer (PFE) is encountering ...

If you are wondering whether Pfizer's current share price reflects its underlying value, you are not alone. This article will walk through what the numbers actually say about the stock. Pfizer's share ...

Pfizer PFE is set to report its fourth-quarter and full-year 2025 earnings on Feb. 3, before market open. The Zacks Consensus ...

Eli Lilly & Company LLY and Pfizer PFE are large-cap U.S. pharmaceutical leaders, each backed by diversified product portfolios and robust R&D engines. Lilly has established a dominant position in ...